2023-05-01 2024-04-30 false No description of principal activity Debitam - Tax and Accounts 1.0 14037495 bus:FullAccounts 2023-05-01 2024-04-30 14037495 bus:Micro-entities 2023-05-01 2024-04-30 14037495 bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 14037495 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 14037495 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 14037495 2023-05-01 2024-04-30 14037495 2024-04-30 14037495 bus:RegisteredOffice 2023-05-01 2024-04-30 14037495 core:WithinOneYear 2024-04-30 14037495 core:AfterOneYear 2024-04-30 14037495 2022-04-10 14037495 bus:Director1 2023-05-01 2024-04-30 14037495 bus:Director1 2024-04-30 14037495 bus:Director1 2022-04-10 2023-04-30 14037495 bus:CompanySecretary1 2023-05-01 2024-04-30 14037495 bus:LeadAgentIfApplicable 2023-05-01 2024-04-30 14037495 2022-04-10 2023-04-30 14037495 2023-04-30 14037495 core:WithinOneYear 2023-04-30 14037495 core:AfterOneYear 2023-04-30 14037495 bus:EntityAccountantsOrAuditors 2022-04-10 2023-04-30 14037495 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 14037495 core:CostValuation core:Non-currentFinancialInstruments 2023-04-30 14037495 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-04-30 14037495 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 14037495 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 14037495 core:Non-currentFinancialInstruments 2024-04-30 14037495 core:Non-currentFinancialInstruments 2023-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14037495
England and Wales

 

 

 


Report of the Director and Unaudited Financial Statements

for the year ended 30 April 2024

for

MIRZA PHARMA LIMITED

 
 
 
£
2024
£
   
£
2023
£
Current assets 29,016  20,776 
Creditors: amount falling due within one year (29,880) (21,110)
Net current assets (864) (334)
Total assets less current liabilities (864) (334)
Net assets (864) (334)
 
Capital and reserves (864) (334)
 
  1. For the year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the companies act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


----------------------------------
Naheed Mirza
Director

Date approved: 29 July 2024
1
Statutory Information
MIRZA PHARMA LIMITED is a private limited company, limited by shares, domiciled in England and Wales, registration number 14037495, registration address 277 Stoops Lane, Doncaster, DN4 7HS, United Kingdom.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1  (2023: 1).
2